期刊文献+

SCID小鼠原位接种LNCaP前列腺癌模型的建立 被引量:9

Establishment of the Orthotopic Implantation Model of the LNCaP Prostate Cancer Cell in SCID Mice
下载PDF
导出
摘要 通过在SCID小鼠前列腺内接种LNCaP前列腺癌细胞建立了原位接种模型并探讨其应用价值。用微量注射器在SCID小鼠的前列腺左右背外侧叶包膜下接种小鼠前列腺癌LNCaP细胞106个建立原位移植瘤模型,以皮下移植瘤模型作为对照比较两者的生存期、肿瘤转移发生情况,并在电镜下观察LNCaP前列腺肿瘤细胞和小鼠正常前列腺组织细胞的特征。结果发现原位模型组小鼠平均生存时间为(21±2.1)d较对照组(35.0±4.5)d明显缩短,差异非常显著(P<0.01);原位模型组小鼠全部发生肿瘤转移,其中盆腔淋巴和肺的转移发生率分别为100%(15/15)、60%(9/15);电镜观察发现SCID小鼠的正常前列腺细胞与癌变后的细胞体积及细胞器均有很大差异。SCID小鼠的前列腺癌原位移植瘤模型较好地模拟了人癌体内的自然生长状况,为进行前列腺癌的研究提供有用的工具。 By the Vaccination of Prostate cancer cells in the Prostate of SCID mice, the paper establishes a Orthotopic model and discusses its value of application. Using the method of micro-syringe, the o.t. implantation model was estabhshed by subcapsulat implantation of 106 mice prostate cancer LNCaP cells into the prostate gland of LNCaP mice. The subcutaneous ( s.b. ) implantation model was used as control. The survival time and the rate of metastasis of these two models were compared. Also the transmission electron microscope was used to observe the difference between the SCID's normal prostate cells and LNCaP cells. The survival lime of o.t. model was ( 21 ± 2.1 )clays, which was markedly shorter than that of s.b. model ( 35.0 ± 4.5 ) days ( P〈0.01 ) . Metastasis occurred in all mice of the o.t. model with the highest rate of pelvic mode ( 100% ) and the lung ( 60% ) . No metastasis was seen in the control group except local growth and infiltration. The result s of transmission electron microscope showed the two types of cells had significant difference in the volume and their organelles. The mice prostate cancer cell lines LNCaP o.t. implantation model is an optimal clinical animal model to observe metastasis the mice natural situation of prostate cancer in its baby quite well.
出处 《北京农业职业学院学报》 2012年第5期19-22,共4页 Journal of Beijing Vocational College of Agriculture
基金 北京农业职业学院技术研发与示范推广基金项目(XY-YF-11-06)的部分研究成果
关键词 LNCAP 原位接种 SCID小鼠 LNCaP, Orthotopic, SCID Mice
  • 相关文献

参考文献12

  • 1Boyle P, Maisonneuve P, Napalkon P. Geographical and temporal patterns of incidence and mortality from prostate cancer [J]. Urology , 1995, 46: 46-47.
  • 2Greenlee R T, Murray T, Bolden S, et al. Cancer statistics 2000 [ J]. CA Cancer J Clin, 2000, 50: 7-33.
  • 3顾方六.前列腺增生和前列腺癌在中国发病情况的初步探讨[J].中华外科杂志,1993,31(6):323-326. 被引量:70
  • 4Walsh P C, Retik A B, Stamey T A, et al. Campbell' s Urology [ M ]. 6th ed. Philadelphia: W. B. Saunders, 1992, 11-85.
  • 5Bosma G C, Custer R P, Bosma M J. A severe combined immunodeficiency mutation in the mouse [ J ]. Nature, 1983, 301: 527-530.
  • 6黄强,衣服新,孙志方,周丽英,王爱东,钱建新,单卫民.严重联合免疫缺陷SCID小鼠的免疫学特征[J].苏州医学院学报,2000,20(7):611-613. 被引量:4
  • 7Taggart B R, Harrington P, Hollingshead M. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model [ J ]. Antiviral Res, 2004, 63 ( 7 ): 1-6.
  • 8Shoker A S, Lun Z R, Choudry R. Cytokine gene expression by alloactivated cells in SCID mice [ J ]. Transpl Immunol, 2002; 10 ( 4 ): 311-320.
  • 9Hamida H, Bait N L, Pierre P, et al. Monocyte- derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement ofCCR7 [ J ].J Immunol, 2002, 169: 1524-1534.
  • 10Kunsffeld R, Wickenhauser G, Michealis U, et al. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model [ J ]. J Invest Dermatol, 2003, 120 ( 3 ): 476-482.

二级参考文献6

共引文献72

同被引文献108

  • 1王元天,孙颖浩,邱镇,顾正勤,许传亮.人类前列腺癌裸鼠原位移植模型的建立[J].中华泌尿外科杂志,2005,26(3):208-209. 被引量:10
  • 2郝捷.2012中国肿瘤登记年报[M].军事医学科学出版社,2012,.
  • 3JEMAL A, BRAY F, CENTER M M, et al. Global cancer statis- tics[J]. CA Cancer J Clin,2011,61 (2) :69-90.
  • 4SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2012 [ J ]. CA Cancer J Clin,2012,62 ( 1 ) : 10-29.
  • 5LEROY B E, NORTHRUP N. Prostate cancer in dogs:compar- ative and clinical aspects [ J ]. Vet J,2009,180 (2) : 149-162.
  • 6HARA T, MIYAZAKI J, ARAKI H, et al. Novel mutations of androgen receptor A possible mechanism of bicalutamide with- drawal syndrome[ J]. Cancer Res ,2003,63 ( 1 ) : 149-153.
  • 7BOBEK V, HOFFMAN R M, KOLOSTOVA K. Site-specific cytomorphology of disseminated PC-3 prostate cancer cells vis- ualized in vivo with fluorescent proteins [ J ]. Diagn Cytopathol, 2012,41 (5) :413-417.
  • 8Van WEERDEN W M, ROMIJN J C. Use of nude mouse xen- ograft models in prostate cancer research[J]. Prostate,2000, 43(4) :263-271.
  • 9WANG Y, REVELO M P, SUDILOVSKY D, et al. Develop- ment and characterization of efficient xenograft models for be- nign and malignant human prostate tissue [ J ]. Prostate,2005, 64(2) :149-159.
  • 10TSINGOTJIDOU A S,ZOTALIS G,JACKSON K R, et al. De- velopment of an animal model for prostate cancer cell metas- tasis to adult human bone[J]. Anticancer Res,2001,21 (2A) : 971-978.

引证文献9

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部